Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
48.63B | 46.94B | 44.81B | 42.75B | 39.54B | Gross Profit |
4.47B | 3.80B | 4.24B | 4.20B | 4.03B | EBIT |
3.24B | 2.62B | 3.18B | 3.22B | 3.14B | EBITDA |
4.61B | 3.69B | 3.95B | 3.96B | 3.75B | Net Income Common Stockholders |
2.39B | 2.04B | 2.28B | 2.34B | 2.26B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.40B | 5.76B | 5.40B | 4.81B | 5.08B | Total Assets |
40.08B | 39.30B | 35.81B | 31.59B | 29.78B | Total Debt |
9.54B | 11.18B | 7.39B | 6.45B | 6.46B | Net Debt |
2.14B | 5.42B | 2.00B | 1.64B | 1.38B | Total Liabilities |
16.87B | 17.77B | 15.66B | 12.98B | 12.86B | Stockholders Equity |
23.20B | 21.53B | 20.15B | 18.61B | 16.92B |
Cash Flow | Free Cash Flow | |||
4.02B | -2.82B | -84.00M | 271.00M | 2.73B | Operating Cash Flow |
4.83B | 2.81B | 3.56B | 1.67B | 3.33B | Investing Cash Flow |
-729.00M | -5.54B | -3.16B | -1.28B | -444.00M | Financing Cash Flow |
-2.45B | 3.08B | 186.00M | -669.00M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥21.85B | 9.15 | 3.35% | 3.60% | 16.83% | ||
74 Outperform | ¥17.10B | 7.41 | 2.75% | 1.73% | -2.77% | ||
74 Outperform | ¥5.86B | 12.57 | 1.87% | 4.81% | -6.89% | ||
73 Outperform | ¥6.70B | 7.00 | 2.12% | 1.73% | -61.62% | ||
72 Outperform | ¥11.32B | 10.15 | 4.08% | 2.56% | 168.27% | ||
66 Neutral | $4.47B | 12.21 | 5.40% | 3.65% | 4.14% | -12.00% | |
63 Neutral | ¥3.72B | 34.43 | 0.82% | 0.09% | 76.91% |